12:00 AM
 | 
Apr 05, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

PMX-30063: Phase Ib data

Data from all 3 segments of a placebo-controlled, multiple-ascending dose Phase Ib trial in 77 healthy volunteers showed that 5-10 doses of 0.08-0.6 mg/kg/day PMX-30063 administered as a single infusion every 12, 24 or 48 hours over 5-10 days were...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >